Discontinuation report APO-BOSENTAN

Last updated on 2018-10-31 History
Report ID 60291
Drug Identification Number 02399210
Brand name APO-BOSENTAN
Common or Proper name BOSENTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) BOSENTAN
Strength(s) 125.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code C02KX
ATC description OTHER ANTIHYPERTENSIVES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-11-01
Actual discontinuation date 2018-10-30
Remaining supply date 2018-10-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2018-10-31 English Compare
v4 2018-10-30 French Compare
v3 2018-10-30 English Compare
v2 2018-09-07 French Compare
v1 2018-09-07 English Compare